New strategy aims to keep breast cancer patients on Life-Saving treatment
NCT ID NCT07071038
Summary
This study aims to help breast cancer patients stay on their hormone therapy by better managing its side effects. Researchers will compare two approaches for women who develop bothersome symptoms: switching to a different medication versus following standard treatment guidelines. The goal is to find the most effective way to control side effects so patients can complete their full 5-year treatment course, which lowers the risk of cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY-STAGE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dartmouth Cancer Center
RECRUITINGLebanon, New Hampshire, 03756, United States
Contact
Conditions
Explore the condition pages connected to this study.